GIPOTIREOZ


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Клинические рекомендации. Гипотиреоз. Российская ассоциация эндокринологов. 2021. Рубрикатор клинических рекомендаций Минздрава России. ID: 531. Доступ: https://cr.minzdrav.gov.ru/schema/531_3 (дата обращения - 01.11.2022)
  2. Perez C.L., Araki F.S., Graf H., de Carvalho G.A. Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 2013; 23(7): 779-84. https://dx.doi.org/10.1089/thy.2012.0435.
  3. Ross D.S. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001; 30(2): 245-64, vii. https://dx.doi.org/10.1016/s0889-8529(05)70186-9.
  4. Woeber K.A. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002; 25(2): 106-9. https://dx.doi.org/10.1007/BF03343972.
  5. Campbell N.R., Hasinoff B.B., Stalts H. et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992; 117(12): 1010-13. https://dx.doi.org/10.7326/0003-4819-117-12-1010.
  6. Zamfirescu I., Carlson H.E. Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 2011; 21(5): 483-86. https://dx.doi.org/10.1089/thy.2010.0296.
  7. Roos A., Linn-Rasker S.P., van Domburg R.T. et al. The starting dose of levothyroxine in primary hypothyroidism treatment: A prospective, randomized, double-blind trial. Arch Intern Med. 2005; 165(15): 1714-20. https://dx.doi.org/10.1001/archinte.165.15.1714.
  8. He Q., Heo M., Heshka S. et al. Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr. 2003; 78(1): 72-77. https://dx.doi.org/10.1093/ajcn/78.1.72.
  9. Eisenberg M., Distefano J.J. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. Thyroid. 2009; 19(2): 103-10. https://dx.doi.org/10.1089/thy.2008.0148.
  10. Biondi B., Palmieri E.A., Lombardi G., Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137(11): 904-14. https://dx.doi.org/10.7326/0003-4819-137-11-200212030-00011.
  11. Paul T.L., Kerrigan J., Kelly A.M. et al. Long-term thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA. 1988; 259(21): 3137-41.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies